Impaired left ventricular relaxation and filling is an important pathophysiologic mechanism in hypertrophic cardiomyopathy. To determine whether isoproterenol, known to improve relaxation in isolated cardiac muscle, could favorably modify this efFect, we assessed simultaneous left ventricular volume and regional systolic asynchrony (by radionuclide angiography), left ventricular pressure (by micromanometer catheters), and lactate metabolism in 12 patients with hypertrophic cardiomyopathy. Pressure-volume relations were studied during atrial pacing stress to induce myocardial ischemia and during isoproterenol infusion to similar heart rates. Angina occurred in 10 patients with pacing and in 11 patients during isoproterenol infusion; lactate consumption was reduced in nine patients during isoproterenol compared with pacing, including five patients who produced lactate with isoproterenol. During isoproterenol compared with pacing, peak left ventricular pressure was higher (205+±33 vs. 142 +21 mm Hg, p <0.001), ejection fraction was higher (77+10% vs. 714±12%, p<0.02), and regional systolic nonuniformity was diminished. Despite ischemia, these changes in load and nonuniformity during isoproterenol were associated with enhanced diastolic function compared with pacing tachycardia: isoproterenol reduced T1/2, the half-time of pressure decline after peak negative dP/dt (from 46+ 10 to 33±6 msec, p <0.001), shifted the diastolic pressure-volume curve downward and rightward in 10 of 12 patients, and increased end-diastolic volume (from 77+18% to 100±11% of control values, p <0.001) with no change in end-diastolic pressure (19+ 7 to 19±5 mm Hg, p=NS). Thus, despite ischemia, isoproterenol improved left ventricular relaxation and filling compared with tachycardia in the absence of ,B-adrenergic stimulation. Although isoproterenol is detrimental in hypertrophic cardiomyopathy by provoking ischemia, these data suggest that the adverse effects of ischemia on ventricular relaxation and distensibility may be alleviated by 3-adrenergic stimulation, possibly as a result of enhanced inactivation and restored load sensitivity. (Circulation 1989;79:371-382) M y yocardial ischemia has been shown in the intact heart to impair left ventricular v relaxation.1-4 Proposed mechanisms for this effect include reduced calcium ion sequestration by the sarcoplasmic reticulum, leading to
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In this study, we sought to determine whether the adverse effects of ischemia on left ventricular relaxation and filling in HCM may be favorably modified by the pharmacologic influence of ,B-adrenergic stim- ulation. In isolated cardiac muscle studies,17 the 03-agonist isoproterenol enhances relaxation even in the absence of a positive effect on contractility; in the intact preparation, it reduces the time constant describing left ventricular pressure fall during isovolumic relaxation.18, 19 We therefore hypothesized that isoproterenol, which has possible detrimental effects in HCM (by increasing contractility, thereby augmenting myocardial oxygen demand and aggravating ischemia), might also have favorable effects by facilitating left ventricular relaxation and filling on the basis of altered loading conditions, changes in nonuniformity, or acceleration of the inactivation process.
Methods

Patient Selection
We studied 12 patients with the clinical and echocardiographic diagnosis of HCM, defined as a hypertrophied, nondilated left ventricle in the absence of an identifiable cardiac or systemic stimulus to hypertrophy.20 There were nine men and three women, ranging in age from 23 to 62 years (mean, 38 years). All patients were symptomatic with either dyspnea or angina and had been treated with either /3-blocking or calcium channel blocking drugs (or both) without satisfactory improvement in symptoms. Catheterization studies were undertaken to determine the presence and magnitude of resting or provocable left ventricular outflow tract obstruction to determine the patient's suitability for operation. All patients gave informed consent for participation in the study protocol. Medications were discontinued for at least 48 hours before catheterization.
Cardiac Catheterization and Hemodynamic
Measurements
The methods in this study were similar to those previously reported in our laboratory. 10, 21 After sedation with 10 mg diazepam administered orally, patients were taken to the catheterization laboratory, usually at 8:00 AM, in the fasting state and without any other premedication. A thermodilution catheter22 (Elecath Corp) was introduced into the right atrium percutaneously via the right internal jugular vein. The great cardiac vein, which is the recipient of blood from the left anterior descending arterial system, was cannulated via the coronary sinus. The thermodilution technique for determining great cardiac vein flow has been described previously. 23, 24 Pacing coronary flow study. Before the pacing coronary flow study, all patients underwent diagnostic right and left heart catheterization. Contrast ventriculography and coronary angiography with multiple angulated views were then performed. All patients had normal coronary arteries (interpreted independently by two experienced observers), as was required for entry into the study.
The study protocol was initiated at least 20 minutes after use of angiographic contrast material so that any effects of the dye on coronary blood flow and metabolism would subside.28 Great cardiac vein flow, lactate, and oxygen content were determined at rest, as were measurements of cardiac output and left ventricular peak systolic and end-diastolic pressure. Pacing via the coronary sinus thermodilution catheter was initiated at a heart rate of 100 beats/ min and maintained for 3 minutes, followed by pacing at 130 beats/min for 3 minutes (except for one patient who was paced at 120 beats/min). Hemodynamic measurements and measurements of coronary flow, lactate, and oxygen content were repeated for each intervention.
Isoproterenol study. After a 10-minute pause to allow baseline conditions to be reestablished, isoproterenol was infused beginning at a rate of 1 ,ugl min and increasing by increments of 1 jug/min at 1-minute intervals to achieve a heart rate of 100 beats/min and maintained for 3 minutes. The infusion was then increased to achieve a heart rate of 130 beats/min for 3 minutes (10 patients 
Effects ofAtrial Pacing
Studies chosen for analysis were those with the highest paced heart rate for which a corresponding isoproterenol study at matched heart rate was performed. The mean paced heart rate for the group was 123±12 beats/min. Coronary sinus flow (measured in 11 patients) increased to 139 ± 47 ml/m (p <0.001 vs. basal flow). Lactate consumption decreased in six patients (one patient produced lactate) and increased in five patients (Table 1) . In the six patients with decreased lactate consumption during pacing, coronary flow increased by an average of 49%, whereas in the four patients with increased lactate consumption, flow increased by C.
. (Figures 2 and 3) , and a pattern of impaired relaxation (i.e., a continuing decline of pressure through late diastole37,38) was observed in seven patients (Figures 3 and 4) .
Effects of Isoproterenol
During isoproterenol infusion, the mean heart rate was 118±13 beats/min, similar to that of pacing. The changes in coronary sinus flow were quite variable; although the mean value was greater than that observed under basal conditions, it was not significantly different from that during pacing. Chest pain occurred in 11 of 12 patients. Changes in myocardial lactate consumption reached borderline statistical significance (p = 0.05). However, compared with the pacing study, lactate consumption decreased in nine of 11 patients during isoproterenol, with five patients producing lactate ( (Figures 2 and 3) . In all 10 of these patients, chest pain consistent with ischemia was present during both interventions. Figures 2 and 3 were obtained in four of these seven patients. LV VOLUME (counts x 103) LV VOLUME (counts x 103) FIGURE 3. Plots of diastolic pressure-volume relations in the same four patients presented in Figure 1 . During atrial pacing, the curves shift upward and leftward, and left ventricular (LV) pressure continues to decline through the filling period (evidence for impaired relaxation38). During isoproterenol, the curves shift downward and rightward toward the baseline, despite more severe myocardial ischemia in all cases, and there is less evidence of impaired relaxation. In this study, we assessed the effect of the pure ,3-adrenergic agonist isoproterenol on indexes of diastolic performance in HCM, a disease in which abnormalities of relaxation and filling play prominent pathophysiologic roles,12 13'5,16 contributing to the genesis of symptoms such as dyspnea, angina, and fatigue. Previous studies involving both isolated cardiac muscle17 and the intact heart18,"9 demonstrate that f8-adrenergic stimulation with isoproterenol improves parameters describing cardiac muscle relaxation. Our results demonstrate that in patients with HCM, /3-stimulation with isoproterenol favorably modifies several measures of diastolic performance when compared with the effects of atrial pacing at similar heart rates. Of note, this evidence of enhanced diastolic function often occurred in the presence of myocardial ischemia, which was in some patients even more severe than that developing during atrial pacing-severe enough to be accompanied by lactate production.
The hemodynamic responses to the two interventions were distinct. Atrial pacing did not alter cardiac output, as stroke volume decreased in response to reduced end-diastolic volume. There was also. an increase in both minimum and enddiastolic left ventricular pressure, associated with an upward shift in the diastolic pressure-volume relation. A pattern of abnormal pressure decay developed in seven patients, with continuing decay of pressure through late diastole.37'38 These hemodynamic changes were accompanied by symptoms compatible with myocardial ischemia in 10 of the patients. During isoproterenol infusion, relative stroke work increased greatly without a significant change in coronary flow, and chest pain compatible with ischemia occurred in 11 patients. The severity of ischemia was often more severe in individual patients during isoproterenol, with actual production of lactate in five patients. In two other patients, stroke work increased in association with reduced coronary flow. Although lactate consumption decreased in these two patients, it remained positive, presumably reflecting a sampling of ischemic and nonischemic regions42 via the great cardiac vein. Potentiation of myocardial demand ischemia would be expected to further delay relaxation, elevate left ventricular diastolic pressures, and aggravate diastolic pressure-volume relations.134344 However, isoproterenol produced the opposite effect and enhanced multiple indexes of left ventricular diastolic performance compared with pacing tachycardia; peak negative dP/dt increased, time to peak negative dP/dt decreased, the time constant of isovolumic pressure decline decreased (returning to baseline values), minimum ventricular diastolic pressure decreased, the diastolic pressure-volume relation shifted downward and rightward, and enddiastolic volume increased with no associated increase in end-diastolic pressure. Thus, compared with pacing, isoproterenol hastened the onset and enhanced the rate (and possibly the extent) of relaxation, associated with improved diastolic distensibility.
As isoproterenol simulates the hemodynamic effects of exercise, these data may explain the common clinical observation that patients with HCM tolerate exercise-induced tachycardia better than spontaneous supraventricular tachycardia at the same heart rate. Our results may also provide a basis for the lack of therapeutic success of f3-blocking drugs in alleviating symptoms in some patients.
Complex and simultaneous changes in hemodynamic and loading conditions preclude definitive statements regarding the mechanism of isoproterenol's beneficial effects on diastolic performance in this study. However 47 This more rapid disappearance of forcegenerating sites would be manifest as an accelerated decay of pressure, indicated in the present study by increased peak negative dP/dt, decreased time constant of relaxation, and reduced time from aortic valve closure to minimum diastolic pressure. Seven of our patients demonstrated a pattern of abnormal pressure decay during pacing ischemia, similar to that described by Lorell et al. 37 An enhanced rate of relaxation in our patients during isoproterenol was associated with a more complete fall in pressure before the onset of filling (Figure 4) .
For a given state of inactivation, loading conditions affect the timing, rate, and extent of relaxation. 5 An enhanced state of inactivation during ,Bstimulation would be expected to heighten the influence of the prevailing loading conditions.5 From our data, several important effects of isoproterenol on ventricular loading are evident. First, left ventricular systolic pressure increased markedly during isoproterenol, due to an aggravation of the outflow tract obstruction. This pressure load in hypertrophic cardiomyopathy may act as a "contraction load,"' tending to delay the onset and slow the rate of relaxation,41'48 although the experimental models supporting this concept may not apply to HCM. Second, it is very likely that systolic shortening was greater during isoproterenol than during pacing, as end-diastolic volume was greater during isoproterenol while end-systolic volume was similar for both interventions. Augmented systolic shortening has been shown to be an important loading parameter resulting in an increased rate of left ventricular relaxation.18'49 Third, isoproterenol resulted in a decrease in the extent of regional nonuniformity (as reflected by the measurements of regional times to minimum volume), another loading influence that would be expected to enhance left ventricular relaxation.5'50 Finally, the mitral regurgitant volume increased during isoproterenol (Table 1) , related to an increase in the outflow tract gradient.41 This may have the loading effect to augment the extent of relaxation by increasing wall stress at the time of mitral valve opening, governed by the LaPlace relation, 551 at a time when the relaxing ventricle is unable to support such a load. Additionally, an increased left atrial-left ventricular pressure gradient would enhance the rate and extent of filling independent of the state of relaxation.52 Hence, the net effect of isoproterenol infusion represents the interaction of these many loading influences with the heightened state of inactivation, with the result being more rapid pressure decay and lower pressures for a given volume during diastole.
There If improved ventricular relaxation and diastolic pressure-volume relations in our patients during isoproterenol resulted from enhanced inactivation despite an ischemic milieu, these results imply that ,8-adrenergic stimulation can overcome the detrimental effects of ischemia on relaxation. Thus, impaired relaxation stemming from myocardial ischemia may be reversible even while the ischemic insult persists. This concept may be analogous to that of "inotropic reserve" in which the reversibility of systolic dysfunction during regional ischemia may be unmasked by inotropic intervention. 58, 59 One of the limitations of our data analysis involves the choice of T1/2 as a "time constant" of isovolumic relaxation. There is no general consensus regarding the best method for calculating a time constant of relaxation, and any method of analysis of pressure decline during isovolumic relaxation in a ventricle that is performing heterogeneously is limited. Chamber pressure in this situation merely reflects the summation of nonuniform rates of relaxation in different parts of the ventricle, and a time constant derived from a decrease in chamber pressure does not necessarily reflect actual changes in relaxation at a cellular level. This is true of most clinical studies of diastolic events in human heart disease and is apt to be particularly so in HCM, due to the marked spatial and temporal heterogeneity of relaxation,36 which may result in a nonexponential decay of pressure.35 '60 In the present study, an attempt was made to fit the pressure data to an exponential model. However, even in several cases with good correlation coefficients, the residuals reflecting the differences between the observed data and the derived curve were consistently nonrandom. Therefore, we chose not to use an exponential curve-fitting model. In a previous study, T1/2 values were shown to correlate well with a "true" time constant derived from nonfilling beats in an intact dog heart model,61 in which pressure fall would more directly reflect the decline in wall tension. In addition, we believe that the concordant and significant changes in T1/2, peak negative dP/dt, time to peak negative dP/dt, and the average rate of pressure decline indicate that the rate of pressure decay was indeed more rapid during isoproterenol compared with pacing tachycardia.
The limitations of using changes in lactate metabolism to reflect the presence or severity of myocardial ischemia have been previously described.42 '62 In this study, we have considered the presence of either lactate production or decreased lactate consumption in association with a decrease in coronary flow and an increase in oxygen demand as indicative of more severe ischemia during isoproterenol compared with pacing. Although intense ,Badrenergic stimulation with isoproterenol (at very high concentrations) may cause lactate production in isolated myocytes and in the isolated heart by stimulating glycogenolysis,63 65 this may reflect relative cellular hypoxia resulting from the markedly increased demand.63'65 It also appears from studies in humans with coronary artery disease given doses of isoproterenol similar to those used in the present study that ischemia is indeed present when lactate is produced.66 '67 In summary, our data demonstrate that ,Badrenergic stimulation with isoproterenol enhances left ventricular relaxation and improves diastolic pressure-volume relations in HCM compared with the effects of pacing tachycardia to the same heart rate. These effects are mediated by load-dependent mechanisms, such as elevated peak systolic pressures, increased systolic shortening, and reduced asynchrony, and possibly also by direct effects on myocardial inactivation. Although it is evident that isoproterenol should not be used in the therapy of ischemia in the presence of HCM, the finding of improved relaxation with isoproterenol despite myocardial ischemia is evidence that the adverse effect of ischemia on diastolic performance might be favorably modified in HCM, at least temporarily, by pharmacological intervention.
